Patent · US Active

Method of treating a proliferative disease

US11007194B2 · kind B2 · utility

1Cited by
18References
32Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 9, 2012
Grant dateMay 18, 2021
Priority date
Expiry dateMar 10, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a method of treating a patient with a serine/threonine kinase inhibitor wherein resistance to the treatment with a serine/threonine kinase inhibitor is suppressed by administering the serine/threonine kinase inhibitor on an intermittent dosing schedule.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.